Global Chicken Vaccines Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chicken Vaccines Market Insights, Forecast to 2034
Vaccination is commonly used in commercial poultry and increasingly in backyard birds to control disease.
Global Chicken Vaccines market is expected to reach to US$ 1330 million in 2024, with a positive growth of %, compared with US$ 1243 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Chicken Vaccines industry is evaluated to reach US$ 1962.6 million in 2029. The CAGR will be 6.7% during 2024 to 2029.
The chicken vaccines market is witnessing significant growth due to the increasing demand for poultry products and the rising prevalence of avian diseases. Chicken vaccines play a crucial role in preventing and controlling viral, bacterial, and parasitic diseases in poultry. The market is driven by factors such as the growth of the poultry industry, rising consumer awareness about food safety, and the need to ensure a healthy and disease-free chicken population. Additionally, advancements in vaccine technology, such as the development of more effective and safer vaccines, are contributing to market growth. However, challenges such as vaccine storage and transportation requirements, and the emergence of new strains of avian diseases, pose potential obstacles. With the continuous focus on disease prevention, biosecurity measures, and sustainable poultry production, the chicken vaccines market is expected to continue its growth trajectory in the coming years.
Report Covers
This report presents an overview of global Chicken Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Chicken Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Boehringer Ingelheim
CEVA
CAHIC
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
Elanco
FATRO
CAVAC
Vaksindo
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Avian Influenza Vaccine
Newcastle Disease Vaccine
Other
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Chicken Vaccines plant distribution, commercial date of Chicken Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Chicken Vaccines introduction, etc. Chicken Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Chicken Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Chicken Vaccines market is expected to reach to US$ 1330 million in 2024, with a positive growth of %, compared with US$ 1243 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Chicken Vaccines industry is evaluated to reach US$ 1962.6 million in 2029. The CAGR will be 6.7% during 2024 to 2029.
The chicken vaccines market is witnessing significant growth due to the increasing demand for poultry products and the rising prevalence of avian diseases. Chicken vaccines play a crucial role in preventing and controlling viral, bacterial, and parasitic diseases in poultry. The market is driven by factors such as the growth of the poultry industry, rising consumer awareness about food safety, and the need to ensure a healthy and disease-free chicken population. Additionally, advancements in vaccine technology, such as the development of more effective and safer vaccines, are contributing to market growth. However, challenges such as vaccine storage and transportation requirements, and the emergence of new strains of avian diseases, pose potential obstacles. With the continuous focus on disease prevention, biosecurity measures, and sustainable poultry production, the chicken vaccines market is expected to continue its growth trajectory in the coming years.
Report Covers
This report presents an overview of global Chicken Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Chicken Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Boehringer Ingelheim
CEVA
CAHIC
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
Elanco
FATRO
CAVAC
Vaksindo
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Segment by Application
Avian Influenza Vaccine
Newcastle Disease Vaccine
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Chicken Vaccines plant distribution, commercial date of Chicken Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Chicken Vaccines introduction, etc. Chicken Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Chicken Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices